Drugs / Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03818763 | Apr 2020 → Mar 2027 expected | hemophilia A | Medical College of Wisconsin | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03818763 ↗ |
| Modality | Cell therapy | “autologous CD34+PBSC, transduced with a lentiviral vector” NCT03818763 ↗ |